5-{[(4-bromophenyl)sulfanyl]methyl}-3-chloro-8-thia-4,6-diazatricyclo[7.4.0.0,2,7]trideca-1(9),2,4,6-tetraene

Catalog No. :
ACKOZN433
CAS No. :
556020-42-9
Molecular Formula :
C17H14BrClN2S2
Molecular Weight :
425.80

IUPAC Name:2-(((4-bromophenyl)thio)methyl)-4-chloro-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidine

5-{[(4-bromophenyl)sulfanyl]methyl}-3-chloro-8-thia-4,6-diazatricyclo[7.4.0.0,2,7]trideca-1(9),2,4,6-tetraene structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$113.00Login to see priceInquiryInquiry
250mg95%$220.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-{[(4-bromophenyl)sulfanyl]methyl}-3-chloro-8-thia-4,6-diazatricyclo[7.4.0.0,2,7]trideca-1(9),2,4,6-tetraene
IUPAC Name2-(((4-bromophenyl)thio)methyl)-4-chloro-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidine
MDL No.MFCD04612953
Molecular FormulaC17H14BrClN2S2
Molecular Weight425.80
SMILESClC1=C2C3=C(CCCC3)SC2=NC(CSC4=CC=C(Br)C=C4)=N1
InChI KeyWSYYMAQOXRQPBB-UHFFFAOYSA-N
Synonym5-{[(4-bromophenyl)sulfanyl]methyl}-3-chloro-8-thia-4,6-diazatricyclo[7.4.0.0,2,7]trideca-1(9),2,4,6-tetraene;[1]Benzothieno[2,3-d]pyrimidine, 2-[[(4-bromophenyl)thio]methyl]-4-chloro-5,6,7,8-tetrahydro-
CAS No.556020-42-9

Synthetic Route by SureRoute

1. ACKOZN433 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKOZN433 route product structure diagram
    ACKOZN433556020-42-9
Inquiry

2. ACKOZN433 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKOZN433 route product structure diagram
    ACKOZN433556020-42-9
Inquiry

Comments (0)